Skip to main navigation
Skip to search
Skip to main content
University of St Andrews Research Portal Home
Help & FAQ
Link opens in a new tab
Search content at University of St Andrews Research Portal
Home
Profiles
Research output
Datasets
Research units
Equipment
Projects
Activities
Impacts
Prizes
Press/Media
Student theses
Risk of AKI with gentamicin as surgical prophylaxis
Samira Bell
*
, Peter Davey
, Dilip Nathwani
,
Charis Marwick
, Thenmalar Vadiveloo
, Jacqueline Sneddon
, Andrea Patton
, Marion Bennie
, Stewart Fleming
, Peter T. Donnan
*
Corresponding author for this work
School of Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Risk of AKI with gentamicin as surgical prophylaxis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Nursing and Health Professions
Gentamicin
100%
Antimicrobial Agent
40%
Policy Change
40%
Antibiotic Prophylaxis
40%
Vascular Surgery
40%
Cephalosporin Derivative
20%
Prevalence
20%
Confidence Interval
20%
Infection
20%
Creatinine
20%
Perioperative Period
20%
Time Series Analysis
20%
Flucloxacillin
20%
Kidney Disease
20%
Orthopedic Surgery
20%
Regression Analysis
20%
Single Drug Dose
20%
Gynecologic Surgery
20%
Gastrointestinal Surgery
20%
Cefuroxime
20%
Medicine and Dentistry
Gentamicin
100%
Acute Renal Failure
100%
Orthopedics
22%
Gynecology
22%
Urology
22%
Antimicrobial Agent
22%
Antibiotic Prophylaxis
22%
Prevalence
11%
Single Drug Dose
11%
Kidney Function
11%
Time Series Analysis
11%
Creatinine
11%
Nephropathy
11%
Perioperative Period
11%
Infection
11%
Flucloxacillin
11%
Cephalosporin Derivative
11%
Orthopedic Surgery
11%
Regression Analysis
11%
Gastrointestinal Surgery
11%
Vascular Surgery
11%
Cefuroxime
11%
Pharmacology, Toxicology and Pharmaceutical Science
Gentamicin
100%
Surgical Prophylaxis
100%
Antimicrobial Agent
40%
Antibiotic Prophylaxis
40%
Kidney Disease
20%
Infection
20%
Prevalence
20%
Creatinine
20%
Flucloxacillin
20%
Cephalosporin Derivative
20%
Cefuroxime
20%